Patents by Inventor Alfred Rudolph

Alfred Rudolph has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100221274
    Abstract: A Thymosin alpha 1 (TA1) peptide is administered to a patient in need of immune stimulation so as to substantially continuously maintain an immune stimulating-effective amount of the TA1 peptide in the patient. The administration method may be by continuous infusion.
    Type: Application
    Filed: May 7, 2010
    Publication date: September 2, 2010
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: ALFRED RUDOLPH, CYNTHIA W. TUTHILL
  • Publication number: 20070087974
    Abstract: An immunomodulatory compound is administered to a patient having, or at risk of a respiratory viral infection.
    Type: Application
    Filed: November 9, 2006
    Publication date: April 19, 2007
    Applicant: SCICLONE PHARMACEUTICALS, INC.
    Inventors: Cynthia TUTHILL, Alfred RUDOLPH, Alexander KOLOBOV, Andrey SIMBIRTSEV, Aleksandr PETROV
  • Publication number: 20070036744
    Abstract: An alpha thymosin peptide is administered to a patient having, or at risk of a respiratory viral infection, coronavirus infection and/or SARS.
    Type: Application
    Filed: April 23, 2004
    Publication date: February 15, 2007
    Applicant: SciClone Pharmaceuticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Publication number: 20060166877
    Abstract: Damage to cells and/or a subject caused by radiation is treated or prevented by administration of an alpha thymosin peptide.
    Type: Application
    Filed: November 25, 2003
    Publication date: July 27, 2006
    Applicant: SciClone Pharmaceticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Publication number: 20060052404
    Abstract: The present invention provides novel pharmaceutical compositions comprising substituted xanthine compounds useful for the treatment of cystic fibrosis and other diseases, and methods of use thereof.
    Type: Application
    Filed: October 3, 2002
    Publication date: March 9, 2006
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Publication number: 20050049191
    Abstract: A Thymosin alpha 1 (TA1) peptide is administered to a patient in need of immune stimulation so as to substantially continuously maintain an immune stimulating-effective amount of the TA1 peptide in the patient. The administration method may be by continuous infusion.
    Type: Application
    Filed: November 1, 2002
    Publication date: March 3, 2005
    Applicant: SicClone Pharmaceuticals, Inc.
    Inventors: Alfred Rudolph, Cynthia Tuthill
  • Patent number: 6837174
    Abstract: The invention relates to a pneumatic bilge liquid removal system including an air compressor having inlet and outlet ports pneumatically coupled to a valve system, a collection chamber with the top segment coupled to the valve system, at least one collection tube extending from the bilge to the collection chamber, a discharge tube coupled to the collection chamber, and a control system for the air compressor and valve system. The air compressor pressurizes the collection chamber via the outlet port for a first time interval causing the bilge liquid in the collection chamber to discharge through the discharge tube, and the air compressor creates a negative pressure in the collection chamber via the inlet port for a second time interval causing any the bilge liquid in the bilge to be drawn into and accumulate in the collection chamber via the collection tubes. A bilge liquid removal method is also provided.
    Type: Grant
    Filed: October 16, 2003
    Date of Patent: January 4, 2005
    Inventor: Alfred Rudolph Baurley